Stock Scorecard
Stock Summary for Teladoc Health Inc (TDOC) - $7.00 as of 1/2/2026 3:47:30 PM EST
Total Score
10 out of 30
Safety Score
41 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for TDOC
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for TDOC
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for TDOC
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for TDOC
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for TDOC (41 out of 100)
| Stock Price Rating (Max of 10) | 4 |
| Historical Stock Price Rating (Max of 10) | 7 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 4 |
| Book Value to Price (Max of 10) | 8 |
| Analyst Buy Ratings (Max of 5) | 4 |
| Analyst Strong Buy Ratings (Max of 5) | 3 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for TDOC
Financial Details for TDOC
Company Overview |
|
|---|---|
| Ticker | TDOC |
| Company Name | Teladoc Health Inc |
| Country | USA |
| Description | Teladoc Health, Inc. is a leading global provider of telehealth solutions, headquartered in Purchase, New York. The company utilizes cutting-edge telemedicine technology to facilitate remote consultations, mental health services, and chronic disease management for patients across the United States and internationally. With a robust network of healthcare professionals, Teladoc is dedicated to enhancing the accessibility, quality, and efficiency of care, positioning itself strongly to meet the rising demand for digital healthcare solutions in a rapidly evolving industry. As a pioneer in telehealth, Teladoc remains committed to advancing patient outcomes through innovative healthcare delivery models. |
| Sector Name | HEALTHCARE |
| Industry Name | HEALTH INFORMATION SERVICES |
| Most Recent Quarter | 9/30/2025 |
| Next Earnings Date | 2/24/2026 |
Stock Price History |
|
| Last Day Price | 7.00 |
| Price 4 Years Ago | 23.65 |
| Last Day Price Updated | 1/2/2026 3:47:30 PM EST |
| Last Day Volume | 4,123,297 |
| Average Daily Volume | 4,679,412 |
| 52-Week High | 15.21 |
| 52-Week Low | 6.35 |
| Last Price to 52 Week Low | 10.24% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 276.99 |
| Sector PE | 52.63 |
| 5-Year Average PE | -13.63 |
| Free Cash Flow Ratio | 1.71 |
| Industry Free Cash Flow Ratio | 16.37 |
| Sector Free Cash Flow Ratio | 30.62 |
| Current Ratio Most Recent Quarter | 2.70 |
| Total Cash Per Share | 4.09 |
| Book Value Per Share Most Recent Quarter | 7.85 |
| Price to Book Ratio | 0.89 |
| Industry Price to Book Ratio | 3.05 |
| Sector Price to Book Ratio | 38.88 |
| Price to Sales Ratio Twelve Trailing Months | 0.50 |
| Industry Price to Sales Ratio Twelve Trailing Months | 4.31 |
| Sector Price to Sales Ratio Twelve Trailing Months | 11.30 |
| Analyst Buy Ratings | 4 |
| Analyst Strong Buy Ratings | 1 |
Share Statistics |
|
| Total Shares Outstanding | 177,473,000 |
| Market Capitalization | 1,242,311,000 |
| Institutional Ownership | 72.00% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | -354.35% |
| Reported EPS 12 Trailing Months | -1.26 |
| Reported EPS Past Year | -0.65 |
| Reported EPS Prior Year | -1.21 |
| Net Income Twelve Trailing Months | -223,588,000 |
| Net Income Past Year | -1,001,245,000 |
| Net Income Prior Year | -220,368,000 |
| Quarterly Revenue Growth YOY | -2.20% |
| 5-Year Revenue Growth | 35.95% |
| Operating Margin Twelve Trailing Months | -5.66% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 726,249,000 |
| Total Cash Past Year | 1,298,327,000 |
| Total Cash Prior Year | 1,123,675,000 |
| Net Cash Position Most Recent Quarter | -267,795,000 |
| Net Cash Position Past Year | 306,909,000 |
| Long Term Debt Past Year | 991,418,000 |
| Long Term Debt Prior Year | 1,538,688,000 |
| Total Debt Most Recent Quarter | 994,044,000 |
| Equity to Debt Ratio Past Year | 0.60 |
| Equity to Debt Ratio Most Recent Quarter | 0.58 |
| Total Stockholder Equity Past Year | 1,491,079,000 |
| Total Stockholder Equity Prior Year | 2,326,073,000 |
| Total Stockholder Equity Most Recent Quarter | 1,392,115,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 198,702,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 1.12 |
| Free Cash Flow Past Year | 282,890,000 |
| Free Cash Flow Prior Year | 193,673,000 |
Options |
|
| Put/Call Ratio | 0.41 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.15 |
| MACD Signal | -0.12 |
| 20-Day Bollinger Lower Band | 6.48 |
| 20-Day Bollinger Middle Band | 7.81 |
| 20-Day Bollinger Upper Band | 9.13 |
| Beta | 2.04 |
| RSI | 37.84 |
| 50-Day SMA | 8.18 |
| 150-Day SMA | 0.00 |
| 200-Day SMA | 19.57 |
System |
|
| Modified | 1/3/2026 9:03:14 AM EST |